Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities
Net loss	$ (12,536)	$ (32,901)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization	452	842
Stock-based compensation	8,633	9,933
Provision for credit losses	(193)	1,020
Common stock warrant liability adjustment	(9,293)	924
Impairment of intangible and other assets	1,904	29
Amortization of right of use assets	929	1,369
Amortization of issuance costs	1,095	0
(Gain)/Loss on Extinguishment of Debt	418	0
(Gain)/Loss on Forgiveness on Interest Accrued	(508)	0
Other adjustments, net	414	80
Changes in assets and liabilities:
Accounts receivable	2,030	965
Prepaid expenses and other assets	(30)	3,177
Inventory	(4,139)	12,118
Accounts payable and accrued and other expenses	1,322	(19,503)
Lease liabilities	(1,178)	0
Other liabilities	(769)	(1,497)
Deferred revenue	240	(84)
Other, net	0	1
Net cash used in operating activities	(11,209)	(23,527)
Cash flows from investing activities
Purchase of property and equipment	(35)	(16)
Purchase of intangible assets	(87)	(43)
Capitalized internal-use software development costs	(639)	0
Net cash used in investing activities	(761)	(59)
Cash flows from financing activities
Proceeds from issuance of preferred stock and warrants, net of $394 and $1,513 of paid transaction costs, respectively	8,855	28,487
Proceeds from issuance of common stock, net of $1,597 of paid transaction costs	10,003	0
Proceeds from short-term borrowings	48,198	28,685
Payments of short-term borrowings	(51,514)	(25,529)
Proceeds from long-term borrowings and issuance of redeemable common stock	7,500	500
Payments of long-term borrowings	(5,000)	(3,500)
Payments related to debt extinguishment costs	(761)	0
Employee taxes paid related to the net share settlement of stock-based awards	(1,031)	(397)
Proceeds related to the net share settlement of stock-based awards	811	427
Debt issuance costs paid	(930)	0
Issuance costs paid related to 2023 preferred stock and warrants		(1,513)
Other, net	363	239
Net cash provided by financing activities	16,044	28,912
Net change in cash, cash equivalents, and restricted cash	4,074	5,326
Cash, cash equivalents, and restricted cash at beginning of period	16,557	11,231
Cash, cash equivalents, and restricted cash at end of period	20,631	16,557
Supplemental disclosure of non-cash financing activities:
Cash paid for income taxes	30	11
Cash paid for interest	4,051	1,876
Conversion of preferred stock	6,469	350
Accretion on preferred stock and redeemable common stock	4,951	4,591
Issuance of common stock warrants to underwriter	382	0
Equity issuance costs included in accounts payable and accrued liabilities	286	450
Reclassification from long-term to current debt	0	500
Stock-based compensation for software development	85	0
Preferred Stock and Warrants
Cash flows from financing activities
Issuance costs paid related to 2023 preferred stock and warrants	$ (450)	$ 0